Listed by the USPTO as SITTON, JEHANNE SOUAYA
Tech Center 1600 • Art Units: 1634 1671 1681 1682 1699
This examiner grants 53% of resolved cases
SITTON, JEHANNE SOUAYA works in Tech Center 1600 and art unit 1634. The profile includes 682 resolved cases and an allowance rate of 53.2%. The interview lift is 47.5%, close to the allowance rate and sufficiently substantial to make examiner interviews a significant consideration. The median time to allowance is 1324 days, so applicants should integrate prosecution timing into portfolio decisions from the outset.
The listed companies are Morehouse School of Medicine, Zoetis LLC, and The Regents of the University of California. The listed firms are FisherBroyles, LLP - MAIN CN, FOLEY & LARDNER LLP, and CARTER, DELUCA & FARRELL LLP. The established record supports structured interview preparation, clear claim differentiation, and preservation of alternative scope.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18655845 | METHODS FOR DETECTING CANCER USING CIRCULATING CELL-FREE DNA | Non-Final OA | Zoetis Services LLC |
| 18557791 | RAPID MILK SAMPLE PREPARATION METHOD COMPATIBLE WITH MOLECULAR TESTS | Non-Final OA | Zoetis Services LLC |
| 18294066 | METHODS FOR DETECTING NEOPLASM IN PREGNANT WOMEN | Final Rejection | Natera, Inc. |
| 18271191 | PARTIAL-EMT SIGNATURE FOR PREDICTION OF HIGH-RISK HISTOPATHOLOGIC FEATURES AND CANCER OUTCOMES ACROSS DEMOGRAPHIC POPULATIONS | Non-Final OA | Massachusetts Institute of Technology |
| 18724591 | LONG NON-CODING RNA BIOMARKER IN EXOSOMES FOR DIAGNOSING ATRIAL FIBRILLATION AND USE THEREOF | Non-Final OA | UIF (University Industry Foundation), Yonsei University |
| 18329972 | THERAPEUTIC AND DIAGNOSTIC METHODS FOR IL-33-MEDIATED DISORDERS | Final Rejection | Genentech, Inc. |
| 18471461 | IDENTIFYING DISEASE-CAUSING HUMAN DDX41 GENETIC VARIANTS | Final Rejection | Wisconsin Alumni Research Foundation |
| 18681427 | GENE/PROTEIN EXPRESSION GUIDED MELANOMA SURGERY | Non-Final OA | The Regents of the University of California |
| 18551396 | METHOD FOR DIAGNOSING DRY MOUTH USING BIOMARKERS | Non-Final OA | The Regents of the University of California |
| 17570315 | METHODS FOR DIAGNOSIS OF BACTERIAL AND VIRAL INFECTIONS | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18429168 | EARLY RISK ASSESSMENT OF PRETERM DELIVERY IN A SUBJECT | Non-Final OA | Tata Consultancy Services Limited |
| 16644650 | Single Immunoglobulin Interleukin-1 Receptor Related (SIGIRR) Variants And Uses Thereof | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 16921287 | METHODS OF PREDICTING PREDISPOSITION TO OR RISK OF KIDNEY DISEASE | Non-Final OA | Wake Forest University Health Sciences |
| 19088496 | METHODS AND MATERIALS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY | Non-Final OA | Myriad Genetics, Inc. |
| 17921936 | COMPOSITIONS AND METHODS FOR SEQUENCING USING POLYMER BRIDGES | Non-Final OA | Illumina, Inc. |
| 18537204 | RNA BIOMARKERS FOR HEREDITARY ANGIOEDEMA | Final Rejection | Takeda Pharmaceutical Company Limited |
| 18248604 | DETERMINATION OF CELLULAR KINETICS AND BIODISTRIBUTION FOR CAR-T CELLS | Non-Final OA | TAKEDA PHARMACEUTICAL COMPANY LIMITED |
| 18561284 | MICRO-RNA DETECTION METHOD AND KIT | Non-Final OA | ZHEJIANG LAB |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy53.2% of resolved applications examined by Jehanne Souaya Sitton were allowed (682 resolved cases), compared with 30.4% across Art Unit 1634 over the last five years.
This examiner's interview lift is +47.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Jehanne Souaya Sitton took 1,324 days on average from filing to allowance.
Jehanne Souaya Sitton examines applications in Art Unit 1634 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
